Found: 7
Select item for more details and to access through your institution.
The Insulin Sensitizer Rosiglitazone Decreases Inflammatory Pattern and Improves Vascular Neuroprotection in Insulin-Resistant Type 2 Diabetic Subjects with Alzheimer's Disease.
- Published in:
- Diabetes, 2007, v. 56, p. A165
- By:
- Publication type:
- Article
Defect of a subpopulation of natural killer immune cells in Graves disease and Hashimotos thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 5, p. 703, doi. 10.1530/eje.1.01906
- By:
- Publication type:
- Article
P3-341: APOE genotype is associated with a general defect of humoral neuroprotection in sporadic mild to moderate Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-281: Advanced glycated end products peptides induce a pathologic release of inflammatory cytokines, expecially during amyloid-beta exposure, in subjects with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-341: APOE genotype is associated with a general defect of humoral neuroprotection in sporadic mild to moderate Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-281: Advanced glycated end products peptides induce a pathologic release of inflammatory cytokines, expecially during amyloid-beta exposure, in subjects with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Decreased Release of the Angiogenic Peptide Vascular Endothelial Growth Factor in Alzheimer’s Disease: Recovering Effect with Insulin and DHEA Sulfate.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2005, v. 19, n. 1, p. 1, doi. 10.1159/000080963
- By:
- Publication type:
- Article